Oligonucleotides services

Syngene’s services encompass therapeutic oligonucleotides, diagnostic oligonucleotides, enzymatic synthesis, and analytical services.

Clinical Development services

Clinical

Syngene supports early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.

Biologics Development and Manufacturing Services

Syngene offers end‑to‑end biologics services across a broad range of modalities and therapeutic areas, including mAbs, recombinant proteins, bispecifics, biosimilars, and antibody–drug conjugates (ADCs).